Regulatory review of drugs and devices: Worksharing with other international regulatory authorities - Canada.ca
Independent archive · Not an official government website · Archived content may be outdated
Regulatory review of drugs and devices: Worksharing with other international regulatory authorities - Canada.ca

Worksharing with other international regulatory authorities

This project will create a streamlined process for joint reviews between Health Canada and other international regulatory authorities.

It will build on our existing relationships with the Australia-Canada-Singapore-Switzerland (ACSS) Consortium. Lessons learned in this worksharing arrangement will help to develop a worksharing framework. This may expand to other national regulatory authorities interested in partnering.

We expect this project to strengthen our partnerships. Partnering in submission reviews will help Canadians gain greater access to new health products that meet health care system needs. This includes drugs for rare diseases.

The tasks for this project include:

We expect that all parts of this project will be fully in place by fall 2020.

Page details

2018-02-16